Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

NYSE:MTAL - New York Stock Exchange, Inc. - JE00BQBC8469 - Common Stock - Currency: USD

11.11  +0.72 (+6.93%)

After market: 11.11 0 (0%)

Fundamental Rating

2

Taking everything into account, MTAL scores 2 out of 10 in our fundamental rating. MTAL was compared to 152 industry peers in the Metals & Mining industry. MTAL may be in some trouble as it scores bad on both profitability and health. MTAL has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MTAL has reported negative net income.
In the past year MTAL had a positive cash flow from operations.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

The Return On Assets of MTAL (-10.88%) is worse than 70.34% of its industry peers.
MTAL has a Return On Equity of -33.10%. This is in the lower half of the industry: MTAL underperforms 77.93% of its industry peers.
Industry RankSector Rank
ROA -10.88%
ROE -33.1%
ROIC N/A
ROA(3y)-2.92%
ROA(5y)N/A
ROE(3y)-17.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20 -30 -40 -50

1.3 Margins

Looking at the Gross Margin, with a value of 11.22%, MTAL is in line with its industry, outperforming 41.38% of the companies in the same industry.
MTAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

MTAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTAL has more shares outstanding
Compared to 1 year ago, MTAL has a worse debt to assets ratio.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M 50M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that MTAL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.30, MTAL is not doing good in the industry: 81.38% of the companies in the same industry are doing better.
The Debt to FCF ratio of MTAL is 132.38, which is on the high side as it means it would take MTAL, 132.38 years of fcf income to pay off all of its debts.
MTAL has a Debt to FCF ratio of 132.38. This is comparable to the rest of the industry: MTAL outperforms 54.48% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that MTAL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.85, MTAL is not doing good in the industry: 87.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 132.38
Altman-Z 0.3
ROIC/WACCN/A
WACC10.34%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.84 indicates that MTAL may have some problems paying its short term obligations.
MTAL has a worse Current ratio (0.84) than 88.97% of its industry peers.
A Quick Ratio of 0.69 indicates that MTAL may have some problems paying its short term obligations.
The Quick ratio of MTAL (0.69) is worse than 84.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.69
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

MTAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1955.34%.
EPS 1Y (TTM)-1955.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-205.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%880.62%

3.2 Future

The Earnings Per Share is expected to grow by 23.58% on average over the next years. This is a very strong growth
MTAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.16% yearly.
EPS Next Y105.26%
EPS Next 2Y60.12%
EPS Next 3Y46.71%
EPS Next 5Y23.58%
Revenue Next Year30.15%
Revenue Next 2Y21.1%
Revenue Next 3Y20.21%
Revenue Next 5Y10.16%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTAL. In the last year negative earnings were reported.
MTAL is valuated rather expensively with a Price/Forward Earnings ratio of 19.36.
MTAL's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of MTAL to the average of the S&P500 Index (91.29), we can say MTAL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 19.36
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTAL is on the same level as its industry peers.
MTAL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 239.2
EV/EBITDA 17.58
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTAL's earnings are expected to grow with 46.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.12%
EPS Next 3Y46.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAC COPPER LTD

NYSE:MTAL (1/29/2025, 8:04:01 PM)

After market: 11.11 0 (0%)

11.11

+0.72 (+6.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-21 2024-10-21/amc
Earnings (Next)N/A N/A
Inst Owners36.14%
Inst Owner Change0%
Ins Owners2.87%
Ins Owner ChangeN/A
Market Cap770.48M
Analysts85.45
Price Target17.75 (59.77%)
Short Float %3.9%
Short Ratio8.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.57%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-91.67%
EPS NY rev (1m)0%
EPS NY rev (3m)134.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)2.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.36
P/S 4.85
P/FCF 239.2
P/OCF 14.39
P/B 1.76
P/tB 1.76
EV/EBITDA 17.58
EPS(TTM)-2.88
EYN/A
EPS(NY)0.57
Fwd EY5.16%
FCF(TTM)0.05
FCFY0.42%
OCF(TTM)0.77
OCFY6.95%
SpS2.29
BVpS6.3
TBVpS6.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.88%
ROE -33.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.22%
FCFM 2.03%
ROA(3y)-2.92%
ROA(5y)N/A
ROE(3y)-17.17%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 132.38
Debt/EBITDA 5.44
Cap/Depr 61.44%
Cap/Sales 31.64%
Interest Coverage N/A
Cash Conversion 78.63%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.69
Altman-Z 0.3
F-Score6
WACC10.34%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1955.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-205.16%
EPS Next Y105.26%
EPS Next 2Y60.12%
EPS Next 3Y46.71%
EPS Next 5Y23.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%880.62%
Revenue Next Year30.15%
Revenue Next 2Y21.1%
Revenue Next 3Y20.21%
Revenue Next 5Y10.16%
EBIT growth 1Y-489.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1263.37%
EBIT Next 3Y168.24%
EBIT Next 5Y79.51%
FCF growth 1Y228.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2241.32%
OCF growth 3YN/A
OCF growth 5YN/A